Biotalys

Founded in 2013 in Ghent (originally under the name AgroSavfe) as a spinoff of Flanders Institute for Biotechnology, Biotalys develops protein-based biocontrol products for crop protection. Its AGROBODY technology platform uses engineered proteins derived from camelid antibody fragments to target crop pests and pathogens with high specificity, offering an alternative to conventional chemical pesticides.

Biotalys is listed on Euronext Brussels and has raised EUR 61M or more in total capital to advance its product pipeline through regulatory approval and toward commercial launch. Biocontrol sits at the intersection of regulatory pressure on chemical pesticides, farm profitability, and growing consumer demand for residue reduction in food.

As a Flanders Institute for Biotechnology spinoff based in Ghent, Biotalys is part of a cluster that includes Protealis and reflects Ghent's position as Belgium's leading agricultural biotech hub.